医学
肝细胞癌
恶病质
全身疗法
肿瘤科
内科学
重症监护医学
癌症
乳腺癌
作者
Shinji Unome,Kenji Imai,Masashi Aiba,Takao Miwa,Tatsunori Hanai,Atsushi Suetsugu,Koji Takai,Masahito Shimizu
标识
DOI：10.1016/j.clnesp.2025.02.018
摘要
Cachexia was prevalent among patients with HCC receiving systemic targeted therapy and was identified as an independent predictor of poorer OS and PPS. Given the prognostic impact, the evaluation of cachexia is crucial in managing patients with HCC undergoing systemic targeted therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
学霸业
小马宝莉
贪玩的秋柔
GingerF
东方鸾
v0id
林狗
黑翅鸢
张张晶晶
激动的从霜
AN
乘11
DIVINEDC
keyanren
李文岐
渡人舟
璐璐
滴滴答答
biu
皖公网安备34019202002308
